Ken Schueler Seminar
2025 Ken Schueler Seminar:
A Deep Dive into Pancreatic Cancer
The 2025 Ken Schueler Cancer Seminar will center on pancreatic cancer, exploring its profound impact on patients, families, and healthcare professionals. Presentations will address the challenges of diagnosing, treating, and managing this complex disease. Additionally, the seminar will emphasize the critical role of advocates in empowering patients and survivors, while highlighting ethical and equitable considerations that advocates should understand to better support those affected.
The Ken Schueler Seminar Series has been Great Success!
The Ken Schueler Seminar Series has been a remarkable success since its launch in 2022, benefiting patients, caregivers, healthcare professionals, and patient advocates alike. Organized by the National Association of Healthcare Advocacy (NAHAC), this series was, established in honor of Kenneth Schueler, one of NAHAC's founding leaders. Ken was a trailblazer in health care advocacy, playing a pivotal role in advancing the patient and health advocacy movement in the United States. His extraordinary contributions to the field and to NAHAC have left a lasting impact, supporting thousands of cancer patients during his distinguished career.
About the Ken Schueler Cancer Seminar
The Ken Schueler Cancer Seminar is more than just a healthcare discussion—it’s a half-day event open to the public for learning, networking, and empowerment. This seminar features a series of engaging, thought-provoking talks by both established and emerging healthcare leaders, offering fresh insights to enhance cancer care for individuals living with cancer, caregivers, patient and health care advocates, and medical professionals alike.
This event goes beyond the traditional conference format, offering concise, impactful presentations alongside engaging panel discussions that foster meaningful dialogue and diverse perspectives. Attendees will not only gain valuable insights from inspiring speakers but also have the opportunity to actively participate—sharing experiences, exchanging ideas, and exploring innovative approaches to cancer care. Expect to leave with fresh perspectives, powerful connections, and a renewed sense of empowerment on your cancer journey."
Kenneth Schueler
A Pioneer in Patient Advocacy
Ken Schueler, often regarded as the Father of Private Patient Advocacy, dedicated his career to empowering patients and shaping the field of healthcare advocacy. After successfully overcoming Stage IV Lymphoma, he began offering advocacy services in 2000, guiding patients in making informed treatment decisions based on the best available evidence and their personal needs. Ken embraced a holistic approach, considering conventional and alternative treatments to ensure patients had comprehensive options.
Before becoming an advocate, Ken’s career was rooted in healthcare, though not in a clinical role. His shift to patient advocacy allowed him to focus on individual care, earning the respect of not only patients and their families but also medical professionals and scientists. Recognizing the need for ethical standards in advocacy, he developed a Code of Ethics, later adopted by the National Association of Health Advocacy Consultants.
As a founding member of the National Association of Healthcare Advocacy (NAHAC), Ken played a pivotal role in advancing the profession. Following his passing in 2011 from pancreatic cancer, his legacy continues through NAHAC’s mission to educate and support healthcare advocates. In March 2022, NAHAC launched the Ken Schueler Seminar Series in his honor, an annual event held every March to further his passion for advancing the profession. Donations made in his honor support this initiative, as well as resources, training, and ethical standards that help advocates guide patients toward high-quality care. Ken’s vision of empowerment, education, and collaboration remains the foundation of patient advocacy today.
Who Should View the Seminar?
This seminar is designed for individuals living with cancer, caregivers, patient and health care advocates, medical professionals, and anyone interested in learning about the latest advancements and insights in cancer treatment.